Sustainable business at Merz Therapeutics
With sales in over 80 countries, our business has a significant impact on the global environment and society.
We have always worked to improve the people’s health in the markets we serve, and since beginning our sustainability journey in 2021, sustainability has become an important factor in how we deliver better outcomes and strive for long-term success.
By joining the UN Global Compact in 2023 and by initiating the EcoVadis Sustainability Rating in the same year, we have opened ourselves up to the outside world. With the UN Global Compact, we have aligned our strategy with global sustainability principles. The submission of EcoVadis and ultimately our good rating in 2024 ensure a high level of transparency towards our trade partners. We will continuously drive the implementation of our Sustainability Strategy through tangible and impactful actions and diligently report on our success, for better outcomes for more patients, people, and the world.
Our Sustainability Strategy is based on an analysis of the most important issues for our business and developed in a way that benefits internal and external stakeholders. There are 4 overarching pillars, which are based on the targets provided by the UN Sustainable Development Goals (UN SDGs).
Our sustainability strategy
- Climate-relevant emissions
- Waste generation, recycling and packaging
Ambition: We always consider positive and negative ecological impacts of our actions and conduct our business in a resource- and climate-friendly manner.
- Employee development
- Employee engagement
- Diversity, inclusion and equal treatment
Ambition: We promote a sustainable work-life balance and create an engaging place of work that encourages employees to be who they are so that they can perform at their best.
- Product quality
- Patient organizations and health education
- Access to health
Ambition: We use our skills to address patients’ unmet needs and improve access to healthcare professionals and other key stakeholders to promote health equity and deliver meaningful value.
- Innovation and R&D
- Customer satisfaction
- Fair business practices and transparency
Ambition: Innovation is the lifeblood of our company. We strive to be genuinely customer-centric and are fully committed to the highest business ethics toward all our stakeholders.
Merz Pharma UK Ltd are committed to supporting the NHS to be the world’s first Net Zero national health service and for us to achieve Net Zero emissions by 2045.
A number of environmental management measures and projects have been completed prior to our baseline year 2022 and there are a range of future Carbon Reduction Initiatives in place.
For more information, view the “Merz Pharma UK Ltd Carbon Reduction Plan – April 2024”.